|
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 5028-5036.
Prepublished online as a Blood First Edition Paper on January 15, 2008; DOI 10.1182/blood-2007-06-097410.
 Previous Article | Next Article 
Submitted June 25, 2007
Accepted December 22, 2007
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles
Daniel L. Sprague, Bennett D. Elzey, Scott A. Crist, Thomas J. Waldschmidt, Robert J. Jensen, and Timothy L. Ratliff*
Department of Urology, University of Iowa, Iowa City, IA, United States
Purdue Cancer Center, Purdue University, West Lafayette, IN, United States
Department of Pathology, University of Iowa, Iowa City, IA, United States
Medical Scientist Training Program, University of Iowa, Iowa City, IA, United States
* Corresponding author; email: tlratliff{at}purdue.edu.
Although mounting evidence indicates that platelets participate in the modulation of both innate and adaptive immunity, the mechanisms by which platelets exert these effects have not been clearly defined. The study reported herein uses a previously documented adoptive transfer model to investigate the ability of platelet-derived membrane vesicles to communicate activation signals to the B cell compartment. The findings demonstrate for the first time that platelet-derived membrane vesicles are sufficient to deliver CD154 to stimulate antigen-specific IgG production and modulate germinal center formation through cooperation with responses elicited by CD4+ T cells. The data are consistent with the hypothesis that platelets modulate inflammation and adaptive immunity at sites distant from the location of activation and that platelet-derived membrane vesicles are sufficient to mediate the effect.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Articles in Blood Online:
-
Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand
- Fabrice Cognasse, Jean Marc Payrat, Larry Corash, Jean Claude Osselaer, and Olivier Garraud
Blood 2008 112: 4779-4780.
[Full Text]
[PDF]
-
Response: Are PDMVs the biologically active source of CD154 in ATR?
- Bennett D. Elzey, Scott A. Crist, Daniel L. Sprague, and Timothy L. Ratliff
Blood 2008 112: 4780-4781.
[Full Text]
[PDF]
-
Microvesicles as immune orchestra conductors
- Mariusz Z. Ratajczak
Blood 2008 111: 4832-4833.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
F. Angelot, E. Seilles, S. Biichle, Y. Berda, B. Gaugler, J. Plumas, L. Chaperot, F. Dignat-George, P. Tiberghien, P. Saas, et al.
Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases
Haematologica,
November 1, 2009;
94(11):
1502 - 1512.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yang, S. Lang, Z. Zhai, L. Li, W. H. A. Kahr, P. Chen, J. Brkic, C. M. Spring, M. J. Flick, J. L. Degen, et al.
Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression
Blood,
July 9, 2009;
114(2):
425 - 436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Cognasse, J. M. Payrat, L. Corash, J. C. Osselaer, and O. Garraud
Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand
Blood,
December 1, 2008;
112(12):
4779 - 4780.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Elzey, S. A. Crist, D. L. Sprague, and T. L. Ratliff
Response: Are PDMVs the biologically active source of CD154 in ATR?
Blood,
December 1, 2008;
112(12):
4780 - 4781.
[Full Text]
[PDF]
|
|
|
|
|
